pharma-company /Medicinal products /Active ingredients

Rx · PZN 19547698

OMVOH 100 mg+200 mg solution for injection in a Fertigspr

German trade nameOMVOH 100 mg+200 mg Injektionslösung in einer Fertigspritze

Active ingredientMirikizumabPharmaceutical formSolution for infusion

Only sporadically available

2.7

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €2,293

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for OMVOH 100 mg+200 mg solution for injection in a Fertigspr.

Review purchasing terms

OMVOH 100 mg+200 mg solution for injection in a Fertigspr contains the active ingredient Mirikizumab and comes as Solution for infusion. One pack size is recorded (PZN 19547698). The pharma availability index for German wholesale stands at 2.7 out of 10 over the past 30 days – the pack was therefore only sporadically available.


OMVOH 100 mg+200 mg solution for injection in a Fertigspr was only sporadically procurable in the past 30 days. We help you identify additional sources of supply and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.